Skip to main content
NIH funding notice RFA-MH-25-186

Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

Closed on August 13, 2024.

Posted
April 29, 2024
Close date
August 13, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $226,902 in first-year total cost, median $226,902.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 CCHI-M (56)]1

Most frequent institutions

  1. UNIVERSITY OF ALABAMA AT BIRMINGHAM1
Competing awards under RFA-MH-25-186 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Pharmacy-centered Rapid ARV Network: Capacity-building for status-neutral ART/PrEP services within Southern community pharmacies1R21AI191580-01GRAVETT, RONNIE MRANA, AADIAUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$226,902ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.